1. Abecasis, A., Wensing, A.M., Vercauteren, J., Paraskevis, D., Van de Vijver, D., Albert, J., Asjo, B., Balotta, C., Bruckova, M., Camacho, R., Coughlan, S., Grossman, Z., Hamouda, O., Hatzakis, A., Horban, A., Korn, K., Kostrikis, L., Kucherer, C., Nielsen, C., Poljak, M., Puchhammer-Stockl, E., Riva, C., Ruiz, L., Salminen, M., Schmit, J.C., Schuurman, R., Sonnerborg, A., Stanekova, D., Stanojevic, M., Struck, D., Boucher, C.A., Vandamme, A.M., on behalf of the SPREAD-programme, 2008. HIV-1 genetic diversity in Europe and its demographic predictors. Demographic determinants of HIV-1 subtype distribution in Europe, 6th European HIV Drug Resistance Workshop, Budapest, Hungary.
2. Investigation of baseline susceptibility to protease inhibitors in HIV-1 subtypes C, F, G and CRF02_AG;Abecasis;Antiviral Therapy,2006
3. Recombination confounds the early evolutionary history of human immunodeficiency virus type 1: subtype G is a circulating recombinant form;Abecasis;Journal of Virology,2007
4. Molecular epidemiological analysis of paired pol/env sequences from Portuguese HIV type 1 patients;Abecasis;AIDS Research and Human Retroviruses,2011
5. Comparative performance of the REGA subtyping tool version 2 versus version 1;Abecasis;Infection, Genetics and Evolution,2010